Skip to main content

Albireo Pharma, Inc.

ALBODelisted Mar 2, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001322505

Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.

13F holders, Q4 2022

Institutional positions in Albireo Pharma, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

ALBO is no longer listed, so this page shows Q4 2022. 13F filings for later quarters list far fewer holders.

Institutional holders
96
−12 vs. Q3 2022
Shares held
18.6M
−660.0K (−3.4%) vs. Q3 2022
Total value
$401.7M
+$29.7M (+8.0%) vs. Q3 2022
New holders
8
41 more added
Sold out
20
31 more reduced

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ALBO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 96 institutions
Q1 2021: 100 institutionsQ2 2021: 99 institutionsQ3 2021: 94 institutionsQ4 2021: 96 institutionsQ1 2022: 109 institutionsQ2 2022: 103 institutionsQ3 2022: 109 institutionsQ4 2022: 96 institutionsQ1 2023: 3 institutionsQ2 2023: 1 institutionQ3 2023: 1 institutionQ4 2023: 1 institutionQ1 2024: 1 institutionQ2 2024: 1 institutionQ3 2024: 1 institutionQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ4 2022: $401.7M
Q1 2021: $589.8MQ2 2021: $546.1MQ3 2021: $477.0MQ4 2021: $362.5MQ1 2022: $495.4MQ2 2022: $352.6MQ3 2022: $372.0MQ4 2022: $401.7MQ1 2023: $2.04MQ2 2023: $756Q3 2023: $744Q4 2023: $744Q1 2024: $744Q2 2024: $744Q3 2024: $744Q4 2024: $744Q1 2025: $744Q2 2025: $744Q3 2025: $744Q4 2025: $44Q1 2026: $44Q2 2026: $44
Institutions holding ALBO and their total value by quarter
QuarterHoldersValue
Q2 20261$44
Q1 20261$44
Q4 20251$44
Q3 20251$744
Q2 20251$744
Q1 20251$744
Q4 20241$744
Q3 20241$744
Q2 20241$744
Q1 20241$744
Q4 20231$744
Q3 20231$744
Q2 20231$756
Q1 20233$2.04M
Q4 202296$401.7M
Q3 2022109$372.0M
Q2 2022103$352.6M
Q1 2022109$495.4M
Q4 202196$362.5M
Q3 202194$477.0M
Q2 202199$546.1M
Q1 2021100$589.8M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Albireo Pharma, Inc.; share changes are against Q3 2022.

Institutions holding ALBO in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
ExodusPoint Capital Management, LP0$00.00%−35,874−100.0%Sold out
New York Life Investments Alternatives0$00.00%−34,524−100.0%Sold out
Prudential Financial Inc0$00.00%−25,700−100.0%Sold out
Ergoteles LLC0$00.00%−19,943−100.0%Sold out
Squarepoint Ops LLC0$00.00%−16,061−100.0%Sold out
Walleye Trading LLC0$00.00%−10,406−100.0%Sold out
Principal Financial Group Inc0$00.00%−10,059−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−10,010−100.0%Sold out
SG Americas Securities, LLC0$00.00%−8,583−100.0%Sold out
Psagot Value Holdings Ltd. / (Israel)0$00.00%−6,800−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−3,304−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−1,000−100.0%Sold out
Macquarie Group Ltd0$00.00%0Sold out
Aquatic Capital Management LLC0$00.00%−200−100.0%Sold out
Cutler Group LP0$00.00%−100−100.0%Sold out
Ellevest, Inc.0$00.00%−21−100.0%Sold out
Wipfli Financial Advisors LLC,––––Not filed